Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GALACTIC: Goal-Directed Afterload Reduction in Acute Heart Failure
NCT00512759Phase 4Completed
- Sponsor
- University Hospital Basel
- Start
- Dec 2007
- Primary completion
- Aug 2018
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of nitroglycerin, hydralazine, ramipril, candesartan in Acute Heart Failure (AHF), sponsored by University Hospital Basel. Started Dec 2007; status: completed.
02
Drugs
nitroglycerinhydralazineramiprilcandesartan
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT00512759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00512759.